(Q41078785)

26 September 2017

1 reference

title

Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury (English)

1 reference

26 September 2017

D J Bjorkman

1

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

American Journal of Medicine

26 September 2017

published in

1 reference

26 September 2017

volume

101

1 reference

26 September 2017

issue

1A

1 reference

26 September 2017

page(s)

25S-32S

1 reference

Nonsteroidal anti-inflammatory drugs: gastropathy, deaths, and medical practice

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs: new insights from observational studies and functional status questionnaires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Overview of clinical cytoprotection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Role of prostaglandins in gastroduodenal mucosal protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Gastric adaptation occurs with aspirin administration in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Immunopathology of NSAID-gastropathy: inhibitory effects of interleukin-I and cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Helicobacter pylori seroprevalence in patients with rheumatoid arthritis: effect of nonsteroidal anti-inflammatory drugs and gold compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

From experiment to experience: Side effects of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Non-steroidal anti-inflammatory drugs and peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Rising frequency of ulcer perforation in elderly people in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Non-steroidal anti-inflammatory drugs and benign oesophageal stricture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Benign stricture of the oesophagus: role of non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Evaluation of the efficacy and comparative effects on gastric and duodenal mucosa of etodolac and naproxen in patients with rheumatoid arthritis using endoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Misoprostol and Nonsteroidal Anti-inflammatory Drugs: A Tale of Effects, Outcomes, and Costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900135-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(96)00135-0

1 reference

26 September 2017

1 reference